Frazier Management as of June 30, 2018
Portfolio Holdings for Frazier Management
Frazier Management holds 13 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 34.1 | $165M | 2.3M | 71.04 | |
| Aptinyx | 16.0 | $77M | 3.2M | 24.17 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 9.3 | $45M | 1.9M | 23.85 | |
| Allena Pharmaceuticals | 9.0 | $43M | 3.3M | 13.03 | |
| Amicus Therapeutics (FOLD) | 8.4 | $41M | 2.6M | 15.62 | |
| Iovance Biotherapeutics (IOVA) | 5.8 | $28M | 2.2M | 12.80 | |
| Sierra Oncology | 5.0 | $24M | 8.1M | 2.96 | |
| Alpine Immune Sciences | 3.5 | $17M | 2.2M | 7.57 | |
| Iterum Therapeutics | 3.4 | $16M | 1.5M | 10.67 | |
| Synlogic | 1.7 | $8.1M | 822k | 9.83 | |
| Bellicum Pharma | 1.6 | $7.8M | 1.1M | 7.38 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.4 | $6.8M | 1.3M | 5.20 | |
| Kezar Life Sciences | 0.9 | $4.3M | 250k | 17.30 |
